The purpose of this study is Safety, Pharmacokinetic Study of PRIC

1. To Compare Pharmacokinetics of PRIC and Pranlukast Dry Syrup
2. To evaluate the safety and tolerability of PRIC and Pranlukast Dry Syrup

Inclusion Criteria:

• 19 to 45 years old healthy male subject at the screening
• Subject who is able to provide written informed consent and decided on his own participation after understanding fully to hear a detailed explanation in the clinical study

Exclusion Criteria:

• Subject with hereditary diseases of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption etc.
• Subjects with history of clinically significant allergy, cardiovascular, peripheral vascular, skin, mucocutaneous, ocular, ear, nose and throat (ENT), respiratory, musculoskeletal, infectious, gastrointestinal, liver, biliary, endocrine, renal, genitourinary, nervous, psychiatric, blood disorders, tumors, fractures or any other conditions